Get the Stockscreener App
4.74
10.23%
0.44
Endra Life Sciences Inc stock is traded at $4.74, with a volume of 31,909.
It is up +10.23% in the last 24 hours and down -5.20% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$4.30
Open:
$4.31
24h Volume:
31,909
Relative Volume:
0.12
Market Cap:
$5.53M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-0.00686
EPS:
-691.4213
Net Cash Flow:
$-8.08M
1W Performance:
-23.55%
1M Performance:
-5.20%
6M Performance:
+52.41%
1Y Performance:
-6.88%
1-Day Range:
$4.1401
$4.90
1-Week Range:
$4.1401
$6.80
52-Week Range:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.74 | 5.02M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Endra Life Sciences Inc Stock (NDRA) Latest News
ENDRA Life Sciences (NASDAQ: NDRA) Advances - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology - Barchart.com
ENDRA Life Sciences (NASDAQ:NDRA) Rating Increased to Sell at Wall Street Zen - Defense World
How Market Conditions Affect Cigniti Technologies Limiteds Growth StrategyHigh Beta Stocks & Double Digit Capital Growth - earlytimes.in
How strong is ENDRA Life Sciences Inc. stock revenue growth2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker - BioSpace
ENDRA’s liver fat measurement device shows strong correlation with MRI By Investing.com - Investing.com Nigeria
ENDRA Life Sciences Inc. (NDRA) -21.7% in Normal Trading: Significant Drop Amid Recent Study Announcement - Stocks Telegraph
ENDRA’s liver fat measurement device shows strong correlation with MRI - Investing.com
How ENDRA Life Sciences Inc. stock performs during Fed tightening cyclesJuly 2025 Fed Impact & Daily Market Momentum Tracking - newser.com
Can ENDRA Life Sciences Inc. rally from current levels2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
What dividend safety score for ENDRA Life Sciences Inc. stock2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
ENDRA Life Sciences Inc. stock daily chart insights2025 Winners & Losers & Technical Pattern Based Buy Signals - newser.com
Why ENDRA Life Sciences Inc. stock remains resilientJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com
When is the best time to exit ENDRA Life Sciences Inc.Market Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
How institutional ownership impacts ENDRA Life Sciences Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Combining machine learning predictions for ENDRA Life Sciences Inc.2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Editor: 【Market Analysis】 - newser.com
The New Era of Treasury Strategy: ENDRA Life Sciences (NASDAQ: NDRA) Impacting Healthcare - openPR.com
Endra Life Sciences Q3 cash burn declines on cost optimization - MarketScreener
ENDRA Life Sciences Q3 cash burn declines on cost optimization - TradingView
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results - Business Wire
ENDRA Life Sciences Granted Nasdaq Compliance Extension - MSN
Can ENDRA Life Sciences Inc. stock beat market expectations this quarterMarket Activity Summary & Risk Controlled Swing Trade Alerts - newser.com
Can ENDRA Life Sciences Inc. recover in the next quarterPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
What the charts say about ENDRA Life Sciences Inc. todayJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com
ENDRA Life Sciences Reports Q3 2025 Financial Results - The Globe and Mail
ENDRA Life Sciences Inc. SEC 10-Q Report - TradingView
ENDRA Life Sciences Regains Nasdaq Compliance - TradingView
Published on: 2025-11-14 14:59:14 - newser.com
Endra Life Sciences commences staking of HYPE digital asset holdings - Yahoo Finance
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Digital Asset Tokenization to Drive Long-Term Shareholder Value - Barchart.com
What to expect from ENDRA Life Sciences Inc. in the next 30 daysInsider Selling & Reliable Breakout Forecasts - newser.com
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):